title: Nanotechnology: Carrying drugs.
authors: Katherine
authors: K
authors: Bourzac
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics*; D002945:Cisplatin / Q000009:adverse effects / Q000493:pharmacokinetics; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000008:administration & dosage / Q000493:pharmacokinetics; D004337:Drug Carriers / Q000008:administration & dosage / Q000737:chemistry* / Q000493:pharmacokinetics*; D019008:Drug Resistance, Neoplasm; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000378:metabolism; D008128:Logic; D050997:Nanomedicine / Q000379:methods*; D053758:Nanoparticles / Q000008:administration & dosage / Q000737:chemistry*; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000008:administration & dosage / Q000235:genetics / Q000493:pharmacokinetics; D012371:Robotics; D013379:Substrate Specificity
chemical_list: D000970:Antineoplastic Agents; D004337:Drug Carriers; D034741:RNA, Small Interfering; D004317:Doxorubicin; D002945:Cisplatin